可药性
G蛋白偶联受体
虚拟筛选
计算生物学
药物发现
功能(生物学)
生物
受体
生物信息学
细胞生物学
遗传学
基因
作者
Sreeparna Majumdar,Yi-Ting Chiu,Julie E. Pickett,Bryan L. Roth
标识
DOI:10.1016/j.drudis.2023.103848
摘要
G-protein-coupled receptors (GPCRs) are the target of >30% of approved drugs. Despite their popularity, many of the >800 human GPCRs remain understudied. The Illuminating the Druggable Genome (IDG) project has generated many tools leading to important insights into the function and druggability of these so-called 'dark' receptors. These tools include assays, such as PRESTO-TANGO and TRUPATH, billions of small molecules made available via the ZINC virtual library, solved orphan GPCR structures, GPCR knock-in mice, and more. Together, these tools are illuminating the remaining 'dark' GPCRs.
科研通智能强力驱动
Strongly Powered by AbleSci AI